upon the expiration of the last patent that is subject to Section 4.2 covering the manufacture, use, sale, offer for sale or import of such Product in such country. 1.20 “Territory ” means, with respect to Licensee, China, and with respect to OMT,...License Agreement • August 8th, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Paragraph 2, above, OMT acknowledges and agrees that Licensee shall have no further obligation to pay any milestone payments under the Agreement. 3. The following shall be added to the end of Section 3.1 of the Agreement: “If, OMT intends to or does...Platform License Agreement • August 8th, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
disposition of a unit of Product to a third party end user (the “ Gross Sales Price ”), after deduction (if not already deducted in the amount invoiced) of the following expenses paid by the Selling Party for such Product that are each actually...Platform License Agreement • August 8th, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
